ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01729806
Brief Title: Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

First Submitted : November 14, 2012
First Submitted that Met QC Criteria : November 14, 2012
First Posted : November 20, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : April 10, 2018
Last Update Posted : April 11, 2018